Avandia - MSN Newsfeeds
- Boston Globe - Steven Haffner of the University of Texas Health Science Center at San Antonio faxed his copy of a report on Avandia to drug maker GlaxoSmithKline 17 days before the article was published online on May 21, 2007, according to the new story in Nature. ...
- Times Online - GlaxoSmithKline, Britain’s biggest drugs maker, is expected to report full-year revenues down by 2.9 per cent on Thursday, with a slump in sales of Avandia, the diabetes treatment linked to heart-attack risk in May, affecting the figures. Novartis ...
- Barron's Online - For Actos, the worry was congestive heart failure; for Glaxo's Avandia, heart attacks. Takeda had hoped to start selling TAK-475 this year. But in light of the FDA's demands for more testing and its increased concern about all diabetes drugs, approval ...
- Street.Com - ... the asthma drug Advair (up 22% to $1.3 billion), the epilepsy drug Lamictal (up 30% to $372 million), the herepes medication Valtrex (up 28% to $313 million), the heart disease drug Coreg (up 50% to $258 million) and the diabetes drugs Avandia and ...
- Financial Times - ... set out his legacy in the 2007 results presentation on Thursday, when he is expected to stress GSK’s strong pipeline of experimental medicines while preparing investors for a difficult period ahead as five products go off patent and sales of Avandia ...
- MSN UK News - GlaxoSmithKline's Avandia diabetes treatment will again be the focus of attention on Thursday when the company posts full-year numbers. In May last year it was rocked by claims - strongly denied by GSK - that the drug increased the risks of heart ...
- Science News - So much for confidential peer review. Last May, a controversial paper in the New England Journal of Medicine ( NEJM ) reported that a popular diabetes drug—rosiglitazone, sold under the brand name Avandia—substantially hikes a user's risk of ...
- Stockhouse Canada - The agency is not taking any chances in this post-Vioxx, post-Bextra, post-Tysabri, post-Avandia world. Leg three is not broken, but it is certainly not inspiring much confidence. We can site three examples of where the FDA blindsided small-cap ...
- New Orleans Times-Picayune - AP) — A Texas doctor leaked confidential research to the makers of the popular diabetes drug Avandia weeks before a study was published tying the drug to higher heart risks, the scientific journal Nature reported Wednesday. • Hand gels alone may ...
- Wall Street Journal - Weeks before an influential article was published last year in the New England Journal of Medicine linking the diabetes drug Avandia to a risk of heart attacks, a physician helping peer-review the article broke the Journal's confidentiality rules and ...
- News.com.au - A TEXAS researcher admitted he had leaked a sensitive and controversial report about the heart risks of diabetes drug Avandia to its maker, GlaxoSmithKline, days before the report was due to be released, it was reported today. Steven Haffner of the ...
- Guardian Unlimited - Sales of Actos, the main earnings engine for Takeda, have risen while those of GlaxoSmithKline's Avandia have tumbled since Avandia was linked to heart attack risk in a U.S. study last May.
- Philadelphia Inquirer - A prominent researcher who reviewed a critical study on the diabetes drug Avandia for a major medical journal leaked the findings before publication to the drug's maker, GlaxoSmithKline P.L.C., according to the journal Nature. The reviewer, Steven M ...
- dBusinessNews.com - Lawsuit Online Signup over Avandia (Rosiglitazone) Side Effects is Announced by the Law Offices of Howard G. Smith PHILADELPHIA -- The Law Offices of Howard G. Smith announces ... Gamesa USA Names Rashid Abdul Senior Vice President of Corporate ...
- dBusinessNews.com - PHILADELPHIA -- The Law Offices of Howard G. Smith announces that an online sign up is available for a lawsuit on the behalf of people injured by taking Avandia. The suit will allege that the manufacturer of the drug, GlaxoSmithKline, failed to ...
- dBusinessNews.com - Lawsuit Online Signup over Avandia (Rosiglitazone) Side Effects is Announced by the Law Offices of Howard G. Smith PHILADELPHIA -- The Law Offices of Howard G. Smith announces ... Gamesa USA Names Rashid Abdul Senior Vice President of Corporate ...
- dBusinessNews.com - Lawsuit Online Signup over Avandia (Rosiglitazone) Side Effects is Announced by the Law Offices of Howard G. Smith PHILADELPHIA -- The Law Offices of Howard G. Smith announces ... Gamesa USA Names Rashid Abdul Senior Vice President of Corporate ...
- dBusinessNews.com - Lawsuit Online Signup over Avandia (Rosiglitazone) Side Effects is Announced by the Law Offices of Howard G. Smith PHILADELPHIA -- The Law Offices of Howard G. Smith announces ... Gamesa USA Names Rashid Abdul Senior Vice President of Corporate ...
- dBusinessNews.com - Lawsuit Online Signup over Avandia (Rosiglitazone) Side Effects is Announced by the Law Offices of Howard G. Smith PHILADELPHIA -- The Law Offices of Howard G. Smith announces ... Gamesa USA Names Rashid Abdul Senior Vice President of Corporate ...
- United Press International - The incident involved a peer reviewer for The New England Journal of Medicine -- Steven Haffner of the University of Texas Health Science Center --who leaked a damaging study concerning GSK's diabetes drug Avandia (rosiglitazone) to the ...
Looking for a Washington, DC Avandia attorney? Get in touch with one of our Washington, DC Avandia attorneys now.
Pages: Previous 1 2 3 4 5 6 7 8 9 10 ... Next
This form is secure and encrypted. More information about secure forms and your privacy here.
Avandia Case Evaluation Form
